Stocks News

LAST PRICE
212.8700
TODAY'S CHANGE (%)
Trending Up2.6800 (1.2750%)

Bid / Lots
201.0000/ 1
Ask / Lots
220.0000/ 2
Open / Previous Close
208.9800 / 210.1900
Day Range
Low 207.9500
High 213.7850
52 Week Range
Low 190.2000
High 261.7300
Volume
1,125,580
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:34 ET (16:34 GMT)
- DJ IQVIA Holdings Is Maintained at Overweight by JP Morgan, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:28 ET (16:28 GMT)
- JPMorgan Cuts Price Target on IQVIA to $240 From $279, Maintains Overweight Rating, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: IQV
  07:01 AM EST, 11/05/2024 (MT Newswires) -- IQVIA Holdings Inc (IQV) has an average rating of outperform and price targets ranging from $195 to $290, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic rese...
Yesterday
- DJ IQVIA Holdings Is Maintained at Buy by Truist Securities, from 10:47AM ET on Monday Nov 04, 2024 by Dow Jones
  10:47AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 04, 2024 10:47 ET (15:47 GMT)
- DJ IQVIA Holdings Is Maintained at Overweight by Morgan Stanley, from 8:23AM ET on Monday Nov 04, 2024 by Dow Jones
  8:23AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 04, 2024 08:23 ET (13:23 GMT)

Today
- Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing, from 8 minutes ago by MT Newswires
  8 minutes ago by MT Newswires
  Companies Mentioned: REGN
- Sector Update: Health Care Stocks Rise Late Afternoon, from 37 minutes ago by MT Newswires
  37 minutes ago by MT Newswires
  Companies Mentioned: MRNA, AZN, PINC, BNOX
- Sector Update: Health Care Stocks Rise Tuesday Afternoon, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: VRTX, MRNA, AZN
- Argus Cuts Biogen's Price Target to $200 From $250, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: BIIB
- Market Chatter: Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: MRNA
- --Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: MRNA
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 7 hours ago by PR Newswire
  7 hours ago by PR Newswire
  Companies Mentioned: MRNA, CARM
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: MRNA, CARM
Yesterday
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors, from 3:00PM ET on Monday Nov 04, 2024 by Dow Jones
  3:00PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: REGN
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors, from 1:24PM ET on Monday Nov 04, 2024 by Dow Jones
  1:24PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: REGN

IQVIA Holdings Inc
NYSE:IQVUnited States

Search Criteria

Today

DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 5 hours ago by Dow Jones

DJ IQVIA Holdings Is Maintained at Overweight by JP Morgan, from 5 hours ago by Dow Jones

JPMorgan Cuts Price Target on IQVIA to $240 From $279, Maintains Overweight Rating, from 9 hours ago by MT Newswires

Yesterday

DJ IQVIA Holdings Is Maintained at Buy by Truist Securities, from 10:47AM ET on Monday Nov 04, 2024 by Dow Jones

DJ IQVIA Holdings Is Maintained at Overweight by Morgan Stanley, from 8:23AM ET on Monday Nov 04, 2024 by Dow Jones

Peers Headlines

Today

Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing, from 8 minutes ago by MT Newswires

Sector Update: Health Care Stocks Rise Late Afternoon, from 37 minutes ago by MT Newswires

Sector Update: Health Care Stocks Rise Tuesday Afternoon, from 2 hours ago by MT Newswires

Argus Cuts Biogen's Price Target to $200 From $250, from 2 hours ago by MT Newswires

Market Chatter: Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post, from 3 hours ago by MT Newswires

--Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports, from 3 hours ago by MT Newswires

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 7 hours ago by PR Newswire

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024, from 7 hours ago by Dow Jones

Yesterday

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors, from 3:00PM ET on Monday Nov 04, 2024 by Dow Jones

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors, from 1:24PM ET on Monday Nov 04, 2024 by Dow Jones